This inventor holds 3 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignee: Geneart Ag. Active years: 2012-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Beratshausen, DE (2012)
- Beratzhausen, DE (2014 - 2019)
Company Filing History:
Years Active: 2012-2019
Title: The Innovations of David Raab
Introduction
David Raab is a notable inventor based in Beratzhausen, Germany. He has made significant contributions to the field of gene expression modulation. With a total of 3 patents to his name, Raab's work focuses on innovative methods that enhance our understanding of genetic modifications.
Latest Patents
One of Raab's latest patents is a method for modulating gene expression by modifying the CpG content. This invention relates to nucleic acid modifications aimed at directed expression modulation through the targeted insertion or removal of CpG dinucleotides. Additionally, it encompasses modified nucleic acids and expression vectors, showcasing the potential for advancements in genetic engineering.
Career Highlights
David Raab is currently associated with Geneart AG, a company known for its expertise in genetic engineering and biotechnology. His work at Geneart AG has allowed him to explore and develop groundbreaking techniques in the field of gene expression.
Collaborations
Raab has collaborated with notable colleagues such as Marcus Graf and Frank Notka. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Raab's innovative work in gene expression modulation highlights the importance of genetic research in modern science. His contributions continue to pave the way for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile